PRP, PRP with Betamethasone, or Betamethasone Injection for Upper Trapezius Myofascial Pain
Official title: Comparison of Platelet-Rich Plasma, Combined Platelet-Rich Plasma Plus Betamethasone, and Betamethasone Monotherapy Trigger Point Injections in Patients With Upper Trapezius Myofascial Pain Syndrome: A Prospective, Randomized, Assessor-Blind, Controlled Trial
Run by University of Kyrenia · NCT07547605 · Data updated 2026-11-12
Three injectable treatments are tested to see which best reduces pain and helps function for people with upper trapezius myofascial pain.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 150 (estimated) |
| Sponsor | University of Kyrenia Academic / other |
| Locations | 2 sites (Kyrenia, Keryneia and 1 other locations) |
| Status | Recruiting |
| Started | May 15, 2026 |
| Main results expected | December 2026 |
| Study ends | January 2027 |
| Registry record updated | June 16, 2026 |
| Trial ID | NCT07547605 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18–65 with upper trapezius myofascial pain syndrome and a single active trigger point who have not responded to at least four weeks of conservative treatment.
✕Probably not a fit
Participants with multiple trigger points, fibromyalgia, cervical radiculopathy, recent trigger point injections, coagulopathy, or allergies to study injectates may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized, assessor-blinded trial compares three injections for upper trapezius myofascial pain: PRP alone, PRP plus betamethasone, and betamethasone alone. It uses a 3-arm design with equal injection volumes and a single center. Participants are adults aged 18–65 with a history of neck/shoulder pain and a diagnosed active trigger point in the upper trapezius who have not responds to at least four weeks of conservative care. Outcomes are assessed to determine which injection approach provides the greatest relief and functional improvement while avoiding biases related to injection volume. Injection technique is palpation-guided without ultrasound assistance, and outcome assessors are blinded to group assignment.
Why it matters
Potential benefit: If successful, patients may experience greater pain relief and improved function with an optimized injection strategy.
How similar studies have gone: Prior studies have explored PRP and corticosteroid injections separately; this trial tests their combination and compares to corticosteroid alone, a relatively novel combination in this specific condition.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age between 18 and 65 years * Presentation to the Orthopedics and Traumatology outpatient clinic with neck and/or shoulder pain * Diagnosis of upper trapezius myofascial pain syndrome based on Simons and Travell criteria, including: * Presence of a taut band * Local tenderness * Referred pain pattern * Local twitch response * Presence of a single active trigger point in the upper trapezius muscle * Symptom duration ≥ 4 weeks * Pain intensity ≥ 4 on the visual analog scale (VAS) * Inadequate response to at least 4 weeks of conservative treatment (physical therapy and/or oral analgesics) * Ability to provide written informed consent Exclusion Criteria: * Presence of multiple active trigger points * Diagnosis of fibromyalgia according to ACR 2010 criteria * Cervical radiculopathy or myelopathy * Trigger point injection in the same region within the past 3 months * Coagulopathy or current anticoagulant or antiplatelet therapy * Known allergy or contraindication to corticosteroids, local anesthetics, or PRP components * Active infection (systemic or local) * Pregnancy or lactation * Thrombocytopenia (platelet count \< 100,000/µL) * Malignancy * Inability to cooperate or provide informed consent
Where it's running
-
Dr. Suat Gunsel University of Kyrenia Hospital
Kyrenia, Keryneia, Cyprus Recruiting -
Dr. Suat Gunsel University of Kyrenia Hospital
Kyrenia, Cyprus Recruiting
Study contacts
- Study coordinator: Utku Gurhan, md
- Email: utkugrhn@gmail.com
- Phone: +905391126898
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Core stability vs scapular stabilization for hand grip in chronic myofascial neck pain
This trial tests whether core stability exercises or scapular stabilization exercises improve hand grip strength in people with chronic myofascial neck pain.
-
Buffered lidocaine for myofascial pain: a comparison with lidocaine alone
This study tests whether adding sodium bicarbonate to lidocaine can improve pain relief for people with myofascial pain syndrome.
-
Magnesium sulfate added to lidocaine for trigger point injections in myofascial pain
This study will see if adding magnesium sulfate to lidocaine injections helps reduce pain and relax muscles in adults with myofascial pain dysfunction syndrome.
-
Dry needling for pain and muscle changes in trapezius trigger points
This trial tests whether dry needling eases pain and produces measurable muscle changes (using electrical impedance myography, threshold tracking, and ultrasound) for people with trigger points in the trapezius.
-
Effects of Different Myofascial Release Techniques on Function in Chronic Neck Pain
This trial tests whether manual or self-applied myofascial release, in addition to standard therapy and exercise, can improve function and reduce pain in adults with chronic non-specific neck pain.
-
Ischemic Compression Plus Home Exercise for Non-Specific Neck Pain
This study tests whether adding ischemic compression to a home exercise program helps reduce neck pain and disability more than home exercise alone in adults with non-specific neck pain.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.